Xolegel (Ketoconazole Topical) - Summary

XOLEGEL SUMMARY

XOLEGEL^TM (KETOCONAZOLE, USP) GEL, 2%
Rx ONLY
FOR TOPICAL USE ONLY.
NOT FOR OPHTHALMIC, ORAL OR INTRAVAGINAL USE.

XOLEGEL Gel contains the antifungal agent ketoconazole USP at 2% in a topical anhydrous gel vehicle.

XOLEGEL Gel is indicated for the topical treatment of seborrheic dermatitis in immunocompetent adults and children 12 years of age and older.

Safety and efficacy of XOLEGEL Gel for treatment of fungal infections have not been established.

XOLEGEL NEWS HIGHLIGHTS

Published Studies Related to Xolegel (Ketoconazole Topical)

A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions. [2007.10]

An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis. [2008.08.01]

The role of ketoconazole in seborrheic dermatitis. [2007.10]

Comparison between fluconazole and ketoconazole effectivity in the treatment of pityriasis versicolor. [2007.07]

A new ketoconazole topical gel formulation in seborrhoeic dermatitis: an updated review of the mechanism. [2007.06]

more>>

Clinical Trials Related to Xolegel (Ketoconazole Topical)

A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults [Completed]

Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors [Active, not recruiting]

Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769] [Completed]

Long Term Study of Extina in Patients With Seborrheic Dermatitis [Recruiting]

Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors [Completed]

more>>